Mark J. Pykett
Overview
Mark J. Pykett received an average of $1M in total compensation, including $286K in salary, at Navidea Biopharmaceuticals from 2010 to 2014.
Source: SEC filings on June 5, 2015, June 6, 2014, and May 24, 2013.
Related executives
We found 17 more executives who work or worked at Navidea Biopharmaceuticals.
Michael Rosol
Navidea Biopharmaceuticals
Chief Medical Officer
Erika Eves
Navidea Biopharmaceuticals
Vice President, Finance & Administration
Jed Latkin
Navidea Biopharmaceuticals
Chief Executive Officer
Michel Mikhail
Navidea Biopharmaceuticals
Chief Regulatory Officer
Joel Kaufman
Navidea Biopharmaceuticals
Former Chief Business Officer
Michael Goldberg
Navidea Biopharmaceuticals
Chief Executive Officer
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
Thomas Klima
Navidea Biopharmaceuticals